Protein Tyrosine Kinase Inhibitor Resistance in Malignant Tumors: Molecular Mechanisms and Future Perspective

Investigators summarize the underlying mechanisms of tyrosine kinase inhibitors (TKIs) resistance and discuss the potential approaches to overcome it, aiming to provide a theoretical basis for improving the efficacy of TKIs for various cancer treatments, including NSCLC.